Concepedia

Procedure guideline for brain death scintigraphy.

Kevin Donohoe, Kirk A. Frey, Victor H. Gerbaudo, Giuliano Mariani, James S. Nagel, Barry L. Shulkin

PubMed · 2003 · 40 citations · 6 references

Concepts

Abstract

The purpose of this guideline is to assist nuclear medicine practitioners in recommending, performing, interpreting, and reporting the results of brain perfusion imaging to assist in confirming the diagnosis of brain death. The diagnosis of brain death is a clinical diagnosis that is sometimes made

References

6

Phase I/II 90 Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma

Gregory A. Wiseman, Christine A. White, Michael Stabin et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 234 citations

, , +15

Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.

Gregory A. Wiseman, Ellen Kornmehl, Bryan R. Leigh et al. · PubMed · 2003 · 216 citations

, , +17

Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach.

R. Dorn, Juergen Kopp, Harry Vogt et al. · PubMed · 2003 · 185 citations

, , +17

Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with (90)Y-labeled anti-CD20 monoclonal antibody.

Henry N. Wagner, Gregory A. Wiseman, Carol S. Marcus et al. · PubMed · 2002 · 169 citations

, , +17

Update on hybrid conjugate-view SPECT tumor dosimetry and response in 131I-tositumomab therapy of previously untreated lymphoma patients.

Kenneth F. Koral, Yuni K. Dewaraja, Jia Li et al. · PubMed · 2003 · 75 citations

, , +17